Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2 .
Dafydd Gareth EvansGeorge Joseph BurghelSacha J HowellSarah PughClaire FordeAnthony HowellFiona LallooEmma Roisin WoodwardPublished in: Journal of medical genetics (2024)
PVs.